Evaluation of Pharmaceutical Care in Depressed Outpatients

N/AUnknownNCT01571973

Federal University of São Paulo60 enrolled

Overview

The study examines whether pharmacotherapeutic follow-up improves outcomes of treatment of depressed outpatients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Depression

Interventions

pharmacotherapeutic follow-upPROCEDURE

health education adjustment of dose improve compliance replacement of medication

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * women between 18 and 65 years, with diagnostic hypothesis of depression at the beginning of treatment or change in treatment unless 2 months (dosage or substance) Exclusion Criteria: * record of dependence on psychoactive substances, diagnosed schizophrenia, * low education (illiterate) or cognitive impairment evident that compromise the completion of research instruments

Outcomes

Primary Outcomes

depression level

evaluation depression level by Beck scale

Time frame: six months

Secondary Outcomes

anxiety level

evaluation anxiety level by Beck scale.

Time frame: 6 months

compliance

evaluation antidepressive treatment compliance by Morisky scale

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.